Literature DB >> 20854170

Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display.

Takeo Kuwata1, Yuko Katsumata, Kaori Takaki, Tomoyuki Miura, Tatsuhiko Igarashi.   

Abstract

The humoral immune response is a mechanism that potently suppresses or prevents viral infections. However, genetic diversity and resistance to antibody-mediated neutralization are serious obstacles in controlling HIV-1 infection. In this study, we isolated monoclonal antibodies from an SIV-infected macaque by using the phage display method to characterize antibodies in SIV infection. Variable regions of immunoglobulin genes were amplified by rhesus macaque-specific primers and inserted into the phagemid pComb3X, which produced the Fab fragment. Antibodies against SIV proteins were selected by biopanning using an SIV protein-coated 96-well plate. A total of 20 Fab clones obtained included 14 clones directed to gp41, four clones to gp120, and two clones to p27. The anti-gp120 Fab clones completely neutralized the homologous neutralization-sensitive SIVsmH635FC and the genetically divergent SIVmac316, and showed at least 50% inhibition against the neutralization-resistant strain, SIVsmE543-3. Competition ELISA revealed that these anti-gp120 Fab clones recognize the same epitope on gp120 including the V3 loop. Identification of antibodies with potent neutralizing activity will help to elucidate the mechanisms for inducing broadly neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854170     DOI: 10.1089/AID.2010.0191

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Analysis of SIVmac Envelope-Specific Antibodies Selected Through Phage Display.

Authors:  Sergio Ita; Mayara R Agostinho; Katherine Sullivan; Seung Yub Han; Rana Akleh; Welkin E Johnson; Ismael Ben F Fofana
Journal:  AIDS Res Hum Retroviruses       Date:  2017-02-16       Impact factor: 2.205

2.  Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.

Authors:  Kejun Guo; Kalani Halemano; Kimberly Schmitt; Miki Katuwal; Yaqiong Wang; Michael S Harper; Karl J Heilman; Takeo Kuwata; Edward B Stephens; Mario L Santiago
Journal:  Immunogenetics       Date:  2015-05-21       Impact factor: 2.846

3.  A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.

Authors:  Saori Matsuoka; Takeo Kuwata; Hiroshi Ishii; Tsuyoshi Sekizuka; Makoto Kuroda; Masato Sano; Midori Okazaki; Hiroyuki Yamamoto; Mikiko Shimizu; Shuzo Matsushita; Yohei Seki; Akatsuki Saito; Hiromi Sakawaki; Vanessa M Hirsch; Tomoyuki Miura; Hirofumi Akari; Tetsuro Matano
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

4.  Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.

Authors:  Takeo Kuwata; Kaori Takaki; Kazuhisa Yoshimura; Ikumi Enomoto; Fan Wu; Ilnour Ourmanov; Vanessa M Hirsch; Masaru Yokoyama; Hironori Sato; Shuzo Matsushita
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

5.  Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.

Authors:  Bin Jia; Lisa K McNeil; Christopher D Dupont; Konstantinos Tsioris; Rachel M Barry; Ingrid L Scully; Adebola O Ogunniyi; Christopher Gonzalez; Michael W Pride; Todd M Gierahn; Paul A Liberator; Kathrin U Jansen; J Christopher Love
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

6.  Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Neutralization-Resistant SIVsmE543-3 Infection.

Authors:  Yuto Nomura; Saori Matsuoka; Midori Okazaki; Takeo Kuwata; Tetsuro Matano; Hiroshi Ishii
Journal:  Viruses       Date:  2021-06-21       Impact factor: 5.048

7.  A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C.

Authors:  Rajesh Kumar; Raiees Andrabi; Ashutosh Tiwari; Somi Sankaran Prakash; Naveet Wig; Durgashree Dutta; Anurag Sankhyan; Lubina Khan; Subrata Sinha; Kalpana Luthra
Journal:  BMC Biotechnol       Date:  2012-11-15       Impact factor: 2.563

8.  Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail.

Authors:  Takeo Kuwata; Takaki Kaori; Ikumi Enomoto; Kazuhisa Yoshimura; Shuzo Matsushita
Journal:  Front Microbiol       Date:  2013-05-14       Impact factor: 5.640

9.  Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Yvonne Liu; Siham Chahboun; Thibaut Pelat; Arnaud Avril; André Frenzel; Thomas Schirrmann; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  MAbs       Date:  2014-01-09       Impact factor: 5.857

10.  Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.

Authors:  Rosemarie D Mason; Hugh C Welles; Cameron Adams; Bimal K Chakrabarti; Jason Gorman; Tongqing Zhou; Richard Nguyen; Sijy O'Dell; Sabrina Lusvarghi; Carole A Bewley; Hui Li; George M Shaw; Zizhang Sheng; Lawrence Shapiro; Richard Wyatt; Peter D Kwong; John R Mascola; Mario Roederer
Journal:  PLoS Pathog       Date:  2016-04-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.